National Peroxide Ltd is Rated Sell

Understanding the Current Rating

The 'Sell' rating assigned to National Peroxide Ltd indicates a cautious stance for investors, suggesting that the stock may underperform relative to the broader market or its sector peers. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s investment potential as of today.

Quality Assessment

As of 26 April 2026, National Peroxide Ltd’s quality grade is considered average. This reflects a company with moderate operational stability but lacking strong growth drivers. Over the past five years, the company has experienced a decline in net sales at an annual rate of -12.60%, signalling challenges in expanding its revenue base. More concerning is the operating profit trend, which has deteriorated sharply with a negative growth rate of -135.58% over the same period. These figures suggest that the company has struggled to maintain profitability and operational efficiency, which weighs heavily on its quality score.

Valuation Perspective

The valuation grade for National Peroxide Ltd is classified as risky. The company is currently trading at valuations that are less favourable compared to its historical averages, indicating that the stock price may not adequately reflect the underlying financial health. The latest data shows a negative EBIT of ₹-6.64 crores, which further emphasises the risk profile. Investors should be wary of the elevated valuation risk, especially given the company’s negative operating profits and subdued growth prospects.

Financial Trend Analysis

Financially, the company exhibits a positive grade, which may seem counterintuitive given the negative operating profits. This positive trend grade likely reflects some stabilisation or improvement in certain financial metrics in the near term. However, the overall returns paint a challenging picture. As of 26 April 2026, National Peroxide Ltd has delivered a one-year return of -35.07%, underperforming the BSE500 index over multiple time frames including the last three years, one year, and three months. The stock’s year-to-date return stands at -14.00%, and the six-month return is down by -32.40%. These figures highlight persistent underperformance and financial strain.

Technical Outlook

The technical grade is mildly bearish, indicating that the stock’s price momentum and chart patterns suggest downward pressure or limited upside potential in the short to medium term. The stock’s recent price movements include a one-day decline of -3.12% and a one-month gain of only +1.99%, which is insufficient to offset longer-term negative trends. This technical assessment aligns with the cautious 'Sell' rating, signalling that market sentiment remains subdued.

Stock Returns and Market Performance

Examining the stock’s returns in detail, the latest data as of 26 April 2026 shows mixed short-term movements but a clear negative trend over longer periods. The one-week return is -0.81%, while the three-month return is -2.91%. These figures, combined with the significant six-month and one-year losses, underscore the stock’s struggles to regain investor confidence. The persistent negative returns, coupled with operational challenges, justify the current 'Sell' rating from a risk management perspective.

Investor Implications

For investors, the 'Sell' rating on National Peroxide Ltd serves as a cautionary signal. It suggests that the stock may not be suitable for those seeking capital appreciation or stable income in the near term. The average quality, risky valuation, and mildly bearish technical outlook imply that the company faces headwinds that could continue to weigh on its share price. Investors should carefully consider these factors alongside their risk tolerance and portfolio objectives before making investment decisions.

Summary of Current Position

In summary, National Peroxide Ltd’s current 'Sell' rating reflects a company facing significant operational and financial challenges. The average quality grade, combined with risky valuation and a mildly bearish technical outlook, suggests limited upside potential. Despite a positive financial trend grade, the stock’s negative returns and declining profitability highlight ongoing risks. Investors should approach this stock with caution and consider alternative opportunities that offer stronger fundamentals and more favourable market dynamics.

Looking Ahead

Going forward, the company’s ability to reverse its negative sales and profit trends will be critical in altering its investment outlook. Improvements in operational efficiency, cost management, and market positioning could enhance quality and valuation metrics. Meanwhile, monitoring technical signals will provide insight into potential shifts in market sentiment. Until such improvements materialise, the 'Sell' rating remains a prudent guide for investors seeking to manage downside risk in their portfolios.

About MarketsMOJO Ratings

MarketsMOJO’s ratings are designed to provide investors with a clear, data-driven assessment of stocks based on multiple dimensions of company performance. The 'Sell' rating indicates that the stock is expected to underperform relative to the market, advising investors to consider reducing exposure or avoiding new purchases. This rating incorporates a holistic view of quality, valuation, financial trends, and technical factors to help investors make informed decisions aligned with their risk appetite.

Final Considerations

As of 26 April 2026, National Peroxide Ltd remains a microcap player in the commodity chemicals sector with a challenging outlook. Investors should weigh the current 'Sell' rating carefully and stay updated on any material changes in the company’s fundamentals or market conditions that could influence future performance.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →